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soronary artery disease (CAD) is a major cause of
orbidity and mortality worldwide. Despite inten-
ive appraisal, there remain questions regarding the
omparative effectiveness of the 2 forms of coro-
ary revascularization therapy: percutaneous coro-
ary intervention (PCI) and coronary artery bypass
raft (CABG) surgery. Clinical experience and
andomized clinical trials have shown that some
atients are better served with PCI, whereas others
xperience more benefit with CABG surgery (1,2).
owever, there remains a large population in
hich the optimal treatment is not well defined.
or example, there has been significant controversy
ately concerning unprotected left main stenting;
lthough CABG has long been considered the
ptimal treatment choice, many interventionalists
elieve that recent evidence may indicate that there
ay now be equipoise between the 2 modalities.
All the existing randomized trials over the past
5 years comparing PCI with CABG surgery in
ultivessel CAD have concluded that, overall,
ABG surgery is associated with fewer long-term
ajor clinical events. However, the observed im-
rom the *Rush Medical College and Advocate Illinois Masonic Medical
enter, Chicago, Illinois; †University of Florida, Shands, Jacksonville,
acksonville, Florida; ‡Duke University Medical Center, Durham, North
arolina; §American College of Cardiology, Heart House, Washington,
C; Interventional Scientific Council, American College of Cardiology,
ashington, DC; and the ¶Christiana Care Health System, Wilming-
on, Delaware. The project described is supported by Award Number
C2HL101489 from the National Heart, Lung, and Blood Institute.
he content is solely the responsibility of the authors and does not
ecessarily represent the official views of the National Heart, Lung, and
lood Institute or the National Institutes of Health. This award has beenC
ssued under the American Recovery and Reinvestment Act of 2009 for
2-year period.rovement in survival is limited to patients with
iabetes, and the benefit of fewer repeat procedures
s most prominent in those with very extensive
AD. The major advantages of CABG surgery are
ts ability to achieve complete revascularization,
articularly in the setting of chronic total occlu-
ion, and the superior durability of its results, with
ess residual angina. Its drawbacks include a rela-
ively long recuperation period and a significant
ncidence of morbidity, including more cerebrovas-
ular events. In contrast, the major advantages of
ontemporary PCI are its noninvasive nature, the
peed of achieving normal or near-normal perfu-
ion in acute coronary syndromes, and relatively
inimal morbidity. Additionally, PCI is also ef-
ective in diminishing anginal symptoms, particu-
arly in high-risk patients. The opportunity for a
ess invasive approach in multivessel CAD seems
o have become more of a reality since the intro-
uction of drug-eluting stents, which have shown
mproved survival in nonrandomized trials and
educed repeat revascularization compared with
lder percutaneous methods. More residual angina
nd more repeat procedures are the critical short-
omings of PCI (3–5).
The National Cardiovascular Disease Registry
orking groups of the American College of Car-
iology (ACC) in collaboration with the ACC
nterventional Scientific Council and the Society
f Thoracic Surgery (STS) effectively collaborated
n developing a unique grant proposal that was
ecently awarded a Grand Opportunity grant by
he National Heart, Lung, and Blood Institute to
tudy the comparative effectiveness of PCI and
ABG surgery for the treatment of stable CAD.
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125his study will compare catheter- and surgery-based pro-
edures using the existing ACC and STS databases, as well
s the Centers for Medicare and Medicaid Services 100%
enominator file data. This study will attempt to bring
larity to the therapeutic decisions required for patients with
ultivessel CAD. The specific patient characteristics that
avor one mode of treatment over the other will be sought
nd details affecting the selection of patients clearly de-
cribed. The findings of this study will help physicians make
etter decisions and improve health care for patients with
AD.
roposed Methodology
he ACC and the STS both have large national multi-
nstitutional registries containing detailed clinical informa-
ion on millions of procedures. Information in these data-
ases generally extends to 1 month after the procedure.
hort-term clinical information from the ACC and STS
egistries will be linked to the administrative data registry
rom the Centers for Medicare and Medicaid Services to
rovide long-term mortality, rehospitalization, and resource
tilization outcomes.
The 3- to 5-year outcomes after CABG surgery will be
ompared with those after contemporary PCI, using pri-
arily drug-eluting coronary stents. In addition to survival,
he need for additional procedures and hospitalizations, new
ardiac disease conditions, and the medications being taken
t various points in time after the coronary artery procedure
ill be assessed. The relative incidences and predisposing
actors to renal failure, stroke, and repeat revascularization
ill be appraised. Special considerations in the selection of
evascularization procedures in important subgroups will be
haracterized in detail, such as patients with other severe
iseases, women, and elderly patients, and addressed. A
omparative analysis in specific anatomic and clinical sub-
ets will be undertaken to assess which therapeutic modality,
f either, would be more favored in a particular population.
In an angiographic substudy, the potential value of the
pplication of the SYNTAX score (4) will be studied. A
ubset of 2,000 patients will be evaluated with regard to
YNTAX score at an angiographic core laboratory. In
ddition, cost analyses as a function of severity of illness and
ength of time from the procedure will be conducted. A
ost-effectiveness analysis will be performed, with the out-
ome expressed as the incremental cost per life-year saved
ith CABG surgery. Net benefit methods will be used that
ill incorporate the propensity for one therapy over another.
atient Population
pproximately 101,000 isolated CABG operations and
86,000 PCI procedures were performed on patients meet-
ng eligibility criteria from 2004 to 2006 at 528 hospitals gubmitting data to both the STS and ACC databases. After
enters for Medicare and Medicaid Services data for 2007
re included, we anticipate approximately an additional 32,000
solated CABG patients and 70,000 PCI patients being
vailable for this study. Various patient subsets can be created
sing a series of clinical and angiographic criteria and results of
ABG surgery and PCI compared in each subgroup.
otential Significance of the Current Study
bservational comparisons from registry databases, al-
hough subject to treatment selection bias, can supplement
andomized controlled trials (RCTs) with larger numbers,
ore “real-world” type patients, and more contemporary
ata, which can be regularly updated. RCT data have been
he cornerstone for comparing therapy for decades. The
CT offers the most satisfactory approach for eliminating
reatment selection bias. However, RCTs have a lack of
eneralizability to the community, considerable expense,
nd results that soon become out of date. Observational
tudies, although having treatment selection bias, can sup-
lement clinical trial data by having greater generalizability,
ower cost, rapid development, large numbers of patients,
nd the opportunity to consider subgroups. RCTs offer a
owerful study design advantage, but they also have signif-
cant drawbacks. The study population of an RCT can be
ery selective, so much so that the study population does not
losely approximate the “average” patient. This is one of the
riticisms of previous RCTs comparing CABG surgery with
CI.
In this study, the focus will be on the patient groups most
ften seen in clinical practice. Furthermore, the total num-
er of patients studied in all RCTs combined is 10,000,
ut there will be 100,000 patients included in this study.
inally, the use of the STS and ACC databases provides an
nprecedented amount of clinical information. Compared
ith RCTs, there is considerably more clinical information
athered in these patients prospectively and from a much
roader range of centers across the country.
Furthermore, many of these trials date from the period of
alloon angioplasty; there has only been 1 trial comparing
rug-eluting stents with CABG surgery, with 1,800 pa-
ients, including only 473 from the U.S. (6). Previously, only
,221 patients were randomized to PCI or CABG surgery
n the U.S. in 2 trials from the balloon angioplasty era from
he late 1980s to the early 1990s (1). More contemporary
utcomes collected in broadly applicable patient subsets are
eeded to assess comparative effectiveness. There have been
bservational comparisons of PCI with CABG surgery,
pecifically from New York State (1), but with smaller
umbers than will be available from the STS and ACC
egistries.
The most significant aspect of the study will be the
eneration of large populations of specific anatomic and
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126linical subsets, with the power to discern the relative
dvantages and disadvantages of each treatment method.
ather than grouping all adverse events of nonequivalent
everity into a single end point category, each type of
dverse event will be analyzed separately. This approach will
llow patients and physicians to make their own value
udgments as to risk and benefit.
Important subsidiary analyses will also have vital conno-
ations for the practice of cardiology in the future. The
YNTAX score has been reported to be highly predictive of
hich therapeutic revascularization procedure should be
avored, based on disease extent, complexity, and severity
6,7). Confirmation in an independent, U.S. dataset could
ave critical implications for its routine clinical application.
dditionally, the economic analysis will generate new in-
ormation regarding the relative value of the 2 treatment
trategies. Cost-effectiveness analysis is a powerful means to
uide both individual treatment choices and assess overall
ealth care policies (8).
The STS and ACC registries have been at the forefront
f quality improvement activities in cardiovascular medicine
or a number of years. Combined, STS and ACC registries
over virtually the entire spectrum of coronary revascular-
zation. These registries contain detailed information col-
ected prospectively, including demographics, cardiovascular
istory, patient risk factors, comorbid illnesses present on
dmission, interventions, care processes, and risk-adjusted
utcomes surrounding specific clinical events.
In conclusion, this study has the potential to provide
ignificant new information that may confirm or change
urrent clinical practice. The focus of the research (PCI vs.
ABG surgery), the use of the 2 most prominent clinical
egistries in the country, and the fact that collaboration
etween STS and ACC covers the entire spectrum of adult
ardiovascular disease promise that the results will be of
reat interest to all physicians. Moreover, the data set will be
arge enough to provide sufficient power to examine patient
ubgroups. This study will be a model for comparative
ffectiveness using nonrandomized data, permitting exten-ive assessment of long-term clinical and economic out-
omes after coronary revascularization from the largest
linical databases concerning revascularization in the world.
Members of the Interventional Scientific Council of the
CC, the STS, and the Cardiothoracic Surgeons Council
f the ACC will be encouraged to generate further hypoth-
ses for substudies as this project develops.
eprint requests and correspondence: Dr. Lloyd W. Klein, Rush
edical College and Advocate Illinois Masonic Medical Center,
75 West North Avenue, Professional Office Building Suite 202,
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